Table 3.
Univariate and Multivariate Analyses of Prognostic Factors Associated with Recurrence-Free Survival
| Variables | Univariate | Multivariate | ||
|---|---|---|---|---|
| HR (95% CI) | P-value | HR (95% CI) | P-value | |
| Age (<18 vs ≥18 years) | 1.23 (0.97–1.57) | 0.098 | ||
| Gender (male vs female) | 1.12 (0.83–1.51) | 0.444 | ||
| Location (femur/tibia vs others) | 1.21 (0.92–1.60) | 0.168 | ||
| Tumor size (≥5 vs <5 cm) | 1.21 (0.76–2.15) | 0.135 | ||
| TNM stage (III–IV vs I–II) | 1.97 (1.53–2.54) | <0.001 | 2.01 (1.54, 2.63) | <0.001 |
| Lung metastasis (yes vs no) | 1.35 (1.12–1.69) | 0.010 | 1.28 (1.04–1.65) | 0.037 |
| miR-183-5p expression (high vs low) | 1.71 (1.25–2.32) | 0.001 | 1.65 (1.17–2.15) | 0.012 |
Note: The bold values denote P-value less than 0.05 with statistical significance.
Abbreviations: HR, hazard ratio; CI, confidence interval.